ANGELALIGN (06699) saw its share price rally following earnings release, with gains expanding to over 10% at the close. As of press time, the stock was up 10.28% to HK$75.1, with turnover reaching HK$573 million.

On the news front, ANGELALIGN announced its interim results for 2025 on the evening of August 25. Revenue reached $161.4 million, representing a 33.1% year-on-year increase. Gross profit amounted to approximately $100 million, up 32.9% year-on-year. Adjusted net profit stood at $19.5 million, surging 84.8% year-on-year. Profit attributable to owners reached $14.643 million, representing a remarkable 362.65% year-on-year growth. Earnings per share came in at $0.09, with a special interim dividend of HK$0.46 per share declared.

During the reporting period, the company's total clear aligner cases increased significantly by 47.7% year-on-year to approximately 225,800 cases. International market cases grew 103.5% year-on-year to approximately 117,200 cases, surpassing the China market's 108,600 cases and demonstrating the significant effectiveness of the company's global expansion strategy.

Additionally, ANGELALIGN announced that its wholly-owned subsidiary Wuxi ANGELALIGN has entered into an investment agreement with Shanghai Marco Fis and existing shareholders of Shanghai Marco Fis. Wuxi ANGELALIGN has conditionally agreed to subscribe for 5% of Shanghai Marco Fis's enlarged registered capital for a cash consideration of RMB 10 million. Upon completion of the investment, the Group will beneficially own approximately 9.7% equity interest in Shanghai Marco Fis.

Shanghai Marco Fis is one of the leading suppliers of raw materials, accessories and equipment in the clear aligner industry. Given the increasing demand for raw materials in the clear aligner production process due to the growth of the Group's clear aligner business, the directors believe it is crucial for the Group to secure reliable raw material suppliers and establish long-term cooperative relationships with such suppliers.